337.1 Total Pancreatectomy with Islet Autotransplantation- Single Center Outcome with Large Cohort of Patients
Dr. Bashoo Naziruddin, United States
337.2 The Epidemiology of Hereditary Pancreatitis in Australia and its effect on patient of Total Pancreatectomy with Islet Auto-Transplantation (TPIAT).
Mr. Denghao Wu, Australia
337.3 Relationship of diabetes technology use with prognosis in people with type 1 diabetes awaiting islet or simultaneous islet kidney transplantation
Dr. Aye Aye Thant, United Kingdom
337.4 Islet-alone vs. islet-after-kidney transplantation glycemic outcomes: Report from the Collaborative Islet Transplant Registry
David A. Baidal, United States
337.5 Islet transplantation versus insulin alone in type 1 diabetic kidney transplant recipients: a French nationwide study on behalf of the TREPID group
Dr. Mehdi Maanaoui, France
337.6 Beta-cell function and insulin sensitivity with islet transplant alone and islet-after-kidney transplantation for type 1 diabetes in the Clinical Islet Transplantation (CIT) Consortium
Dr. Michael R Rickels, United States
337.7 BETA-2 scores overestimate graft function in pancreatic islet transplant recipients with an estimated glomerular filtration rate of <30 ml/min/1.73m2
Dr. Braulio A Marfil-Garza, Canada
337.8 Cost Savings Using The BETA-2 Versus Beta Score In Follow-Up Of Islet Transplant Recipients In The UK Islet Transplant Consortium.
Prof. Shareen Forbes, United Kingdom
337.9 Glucose-Dependent Insulin Production and Insulin-Independence in Type 1 Diabetes from Stem Cell-Derived, Fully Differentiated Islet Cells: Updated Data from the VX-880 Clinical Study